trial · primary record
Dupilumab
Pruritis
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 46 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Itch Severity Scale (ISS) Scores |
| Registry ID | NCT06226610 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:44:04.256Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06226610
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Dupilumab · compound